Haeyoung Suh-Kim

CEO at CELLeBRAIN

Speaker

Dr. Haeyoung Suh-Kim received her early education at Seoul National University and earned her Ph.D. from Baylor College of Medicine. Her early research focused on brain development and G-protein signaling to the nervous system. Currently, her work is centered on mesenchymal stem cell (MSC)-based gene therapy, harness the innate of MSCs to home to tumors and injured sites, She has developed innovative methods to disease-specific engineering MSCs, aiming to overcome the delivery barriers of conventional gene therapy and enhance the therapeutic potential of MSCs.
Dr. Suh-Kim is the Founder and CEO of CELLeBRAIN, where she is dedicated to translating her academic discoveries at Ajou University into clinical applications, with the goal of delivering transformative therapies to patients with unmet medical needs.